Thursday, January 26, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

DRIVe: Accelerating National Health Security Innovation

by Stephanie Lizotte
April 29, 2018
Biomedical Countermeasures

The Biomedical Advanced Research and Development Authority (BARDA), Division of Research, Innovation and Ventures (DRIVe) is seeking applicants interested in working with BARDA DRIVe as part of a network of accelerators across America to promote national health security innovation.

The DRIVe Accelerator Network will leverage key regional hubs where health security products and technologies in biotechnology, life science research, and medical innovations are most heavily occurring, and will increase the growth potential in other regions across the US.

The Accelerator Network aims to:

  • Support BARDA DRIVe health security products and technologies as they navigate research, development, and regulatory pathways
  • Provide services to assist R&D efforts (technical advice, access to facilities and incubator spaces, integration services)
  • Identify and foster innovations in early health security product and technology development
  • Cultivate the community of those making a difference in health security products, technologies and innovations

The goal will be to populate the R&D pipeline with candidate health security products and technologies that are ready to advance to later-stage funding outside of the accelerator network for clinical development and commercialization, to revolutionize our capability and capacity for national health security preparedness and response.

Further details are available via Funding Opportunity Number: EP-IDS-18-001. Applications are due May 17, 2018.

Sources: FBO.gov, Grants.gov, Phe.gov

Read also:

  •  Combating Antibiotic Resistant Bacteria (CARB) Biopharmaceutical Accelerator
Tags: ASPRBARDAHHSRFI

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC